Biologics

EU approval for Regeneron and Sanofi’s rheumatoid arthritis drug

By Niamh Marriott (Junior Editor: European Pharmaceutical Review)

FDA approves BioMarin’s manufacturing facility in Cork, Ireland

By Niamh Marriott (European Pharmaceutical Review)

Leading European health start ups join forces to better serve insurers

By Niamh Marriott (European Pharmaceutical Review)

Wickham Laboratories Limited

Takara Clontech

New England Biolabs, Inc.

Asia-Pacific asthma market will hit $6 billion by 2023

By Niamh Marriott (European Pharmaceutical Review)

EUROGENTEC

Biologics before triple therapy not cost effective for rheumatoid arthritis

By American College of Physicians

Pharma Digitalisation: Challenges and opportunities in transforming the pharma industry

By Pasi Kemppainen, Executive Consultant, Pharma Digitalisation and Sammeli Liikkanen, Chief Digital Officer, Orion Pharma

Why biosimilars are changing the pharmaceutical industry

By Ho-ung Kim, Head of Strategy and Operations Division for Celltrion Healthcare

Bioreactors and Fermenters market to reach US $4461 million by 2024

By European Pharmaceutical Review

Issue #2 2017 – Digital version

By European Pharmaceutical Review

Mass Spectrometry In-Depth Focus 2017

By European Pharmaceutical Review

Rethinking Collaboration in Biologics Discovery

By Dassault Systèmes BIOVIA